Catalyst is a leading private equity firm in Israel with more than $250 million in assets under management. Since its founding in 1999, Catalyst has successfully completed over 25 investments and raised three funds.
Catalyst uses its knowledge, experience and resources to invest sensibly, create value for its portfolio companies and generate maximum returns for investors. We typically support capital and long-term growth of mature Israeli and Israeli-related innovative companies that have significant revenue, an impressive management team and a meaningful growth potential in global markets, with a special focus on China and other emerging markets. We at Catalyst see our platform as a highly effective conduit for Israeli innovative companies who are seeking global expansion, with a special emphasis on market entry into China backed by strong partners.
Catalyst leverages its unparalleled access to Israeli deal flow and global based network of partners, investors and strategic relationships across Israel, Europe, the US and China to create value for both our investors and our portfolio companies. Our managing partners enjoy a global and multidisciplinary background, wide-reaching operational, financial and sector expertise, significant business networks and vast transactional experience in global capital markets and cross-border M&A.
Catalyst’s current and past portfolio of companies include: Mobileye (NASDAQ, market cap $8.8B), Omrix Biopharmaceuticals (IPO on NASDAQ and then acquisition by Johnson & Johnson), Orex CR Technologies (acquired by Kodak), Lamina Technologies, Dori Media Group, Tufin and many others.